Example: quiz answers
Package leaflet: Information for the user Shingrix powder ...
vaccine. Shingrix can be given at t he same time as other vaccines. A different injection site will be used for each vaccine. You may be more likely to experience feve r and/or shivering when 23- valent pneumococcal polysaccharide vaccine is given at the same time as Shingrix . Pregnancy and breast-feeding
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
Herpes Zoster (Shingles) Vaccine – Shingrix (Var-SI)
www.albertahealthservices.caThe Shingrix vaccine is only licensed for people age 50 years and older, but vaccine experts agree that younger people who have had or are going to have an organ transplant should get it (this is also called off-label use). Talk to your healthcare provider to decide if this vaccine is
COMPLETING THE 2-DOSE SERIES OF SHINGRIX
mms-cms.mckesson.comSHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older. SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox). Important Safety Information • SHINGRIX is contraindicated in anyone with a history of a severe allergic reaction (eg, anaphylaxis) to any
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euPPV23 vaccine (N=865; Zoster-035) or a dTpa vaccine formulated with 0.3 milligrams Al3+ (N=830; Zoster-042). The immune responses of the co-administered vaccines were unaffected, with the exception of lower geometric mean concentrations (GMCs) for one of the pertussis antigens (pertactin) when Shingrix is co-administered with the dTpa vacci ne.
Standing Orders for Administering Recombinant Zoster ...
www.immunize.org4 Prepare to Administer Vaccine. For administration of RZV (Shingrix), administer 0.5 mL intramuscularly according to the following chart: gender and weight of patient needle gauge needle length injection site. Female or male less than 130 lbs 22–25 ⅝"*–1" Deltoid muscle of arm
Vaccine Shingrix Zostavax - BCBSTX
www.bcbstx.comVaccine Shingrix Zostavax Dosage schedule Two doses (2nd dose 2-6 months later) One dose Vaccine description Recombinant, adjuvanted Live-attenuated FDA recommended age Adults 50 and older even if previously vaccinated with Zostavax Adults …
Shingrix, INN-Herpes zoster vaccine (recombinant, adjuvanted)
www.ema.europa.euShingrix . International non-proprietary name: herpes zoster vaccine (recombinant, adjuvanted) Procedure No. EMEA/H/C/004336/0000 . Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted.
Press release Full year and fourth quarter 2020 - GSK
www.gsk.comShingrix growth in Europe, China and the US together with Cervarix strong performance in China. Reported Consumer Healthcare sales grew 12% AER and 14% CER to £10,033 million for the full year, largely driven by the inclusion of the Pfizer portfolio, partly offset by brands divested/under review. On a pro-forma basis, sales declined
Vaccine Information Statement: Recombinant Zoster ...
www.cdc.govrecombinant shingles vaccine. Your health care provider can give you more information. 4. Risks of a vaccine reaction A sore arm with mild or moderate pain is very common after recombinant shingles vaccine. Redness and swelling can also happen at the site of the injection. Tiredness, muscle pain, headache, shivering,